203 related articles for article (PubMed ID: 32886538)
1.
Augustin LB; Milbauer L; Hastings SE; Leonard AS; Saltzman DA; Schottel JL
J Drug Target; 2021 Mar; 29(3):294-299. PubMed ID: 32886538
[TBL] [Abstract][Full Text] [Related]
2. Attenuated Salmonella enterica Typhimurium reduces tumor burden in an autochthonous breast cancer model.
Drees J; Mertensotto M; Liu G; Panyam J; Leonard A; Augustin L; Schottel J; Saltzman D
Anticancer Res; 2015 Feb; 35(2):843-9. PubMed ID: 25667465
[TBL] [Abstract][Full Text] [Related]
3. Virulence-attenuated
Augustin LB; Milbauer L; Hastings SE; Leonard AS; Saltzman DA; Schottel JL
J Drug Target; 2021 Apr; 29(4):430-438. PubMed ID: 33183080
[TBL] [Abstract][Full Text] [Related]
4. Vasculature Disruption Enhances Bacterial Targeting of Autochthonous Tumors.
Drees JJ; Mertensotto MJ; Augustin LB; Schottel JL; Saltzman DA
J Cancer; 2015; 6(9):843-8. PubMed ID: 26284135
[TBL] [Abstract][Full Text] [Related]
5. Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice.
Ganai S; Arenas RB; Forbes NS
Br J Cancer; 2009 Nov; 101(10):1683-91. PubMed ID: 19861961
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a highly attenuated Salmonella enterica serovar Typhimurium mutant strain.
Tang IK; Ji DD; Chou CF; Lin HC; Liao CL; Sytwu HK; Wang JJ; Liu YT
J Microbiol Immunol Infect; 2002 Dec; 35(4):229-35. PubMed ID: 12542248
[TBL] [Abstract][Full Text] [Related]
7. Lon, a stress-induced ATP-dependent protease, is critically important for systemic Salmonella enterica serovar typhimurium infection of mice.
Takaya A; Suzuki M; Matsui H; Tomoyasu T; Sashinami H; Nakane A; Yamamoto T
Infect Immun; 2003 Feb; 71(2):690-6. PubMed ID: 12540547
[TBL] [Abstract][Full Text] [Related]
8. Molecular and functional characterization of Salmonella enterica serovar typhimurium poxA gene: effect on attenuation of virulence and protection.
Kaniga K; Compton MS; Curtiss R; Sundaram P
Infect Immun; 1998 Dec; 66(12):5599-606. PubMed ID: 9826331
[TBL] [Abstract][Full Text] [Related]
9. Low dose chemotherapy combined with attenuated Salmonella decreases tumor burden and is less toxic than high dose chemotherapy in an autochthonous murine model of breast cancer.
Saltzman D; Augustin L; Leonard A; Mertensotto M; Schottel J
Surgery; 2018 Mar; 163(3):509-514. PubMed ID: 29229318
[TBL] [Abstract][Full Text] [Related]
10. Influence of infection route and virulence factors on colonization of solid tumors by Salmonella enterica serovar Typhimurium.
Crull K; Bumann D; Weiss S
FEMS Immunol Med Microbiol; 2011 Jun; 62(1):75-83. PubMed ID: 21314734
[TBL] [Abstract][Full Text] [Related]
11. Solid tumors provide niche-specific conditions that lead to preferential growth of Salmonella.
Silva-Valenzuela CA; Desai PT; Molina-Quiroz RC; Pezoa D; Zhang Y; Porwollik S; Zhao M; Hoffman RM; Contreras I; Santiviago CA; McClelland M
Oncotarget; 2016 Jun; 7(23):35169-80. PubMed ID: 27145267
[TBL] [Abstract][Full Text] [Related]
12. Optimization of tumor-targeted gene delivery by engineered attenuated Salmonella typhimurium.
Mei S; Theys J; Landuyt W; Anne J; Lambin P
Anticancer Res; 2002; 22(6A):3261-6. PubMed ID: 12530073
[TBL] [Abstract][Full Text] [Related]
13. The impact of sseK2 deletion on Salmonella enterica serovar typhimurium virulence in vivo and in vitro.
Zhang X; He L; Zhang C; Yu C; Yang Y; Jia Y; Cheng X; Li Y; Liao C; Li J; Yu Z; Du F
BMC Microbiol; 2019 Aug; 19(1):182. PubMed ID: 31390974
[TBL] [Abstract][Full Text] [Related]
14. A multi-drug resistant Salmonella Typhimurium ST213 human-invasive strain (33676) containing the bla CMY-2 gene on an IncF plasmid is attenuated for virulence in BALB/c mice.
Wiesner M; Calva JJ; Bustamante VH; Pérez-Morales D; Fernández-Mora M; Calva E; Silva C
BMC Microbiol; 2016 Feb; 16():18. PubMed ID: 26862033
[TBL] [Abstract][Full Text] [Related]
15. Role of trehalose biosynthesis in environmental survival and virulence of Salmonella enterica serovar typhimurium.
Howells AM; Bullifent HL; Dhaliwal K; Griffin K; García de Castro A; Frith G; Tunnacliffe A; Titball RW
Res Microbiol; 2002 Jun; 153(5):281-7. PubMed ID: 12160319
[TBL] [Abstract][Full Text] [Related]
16. Mucosal and systemic immune responses to chimeric fimbriae expressed by Salmonella enterica serovar typhimurium vaccine strains.
Chen H; Schifferli DM
Infect Immun; 2000 Jun; 68(6):3129-39. PubMed ID: 10816454
[TBL] [Abstract][Full Text] [Related]
17. Tumor-targeting amino acid auxotrophic Salmonella typhimurium.
Hoffman RM
Amino Acids; 2009 Sep; 37(3):509-21. PubMed ID: 19291366
[TBL] [Abstract][Full Text] [Related]
18. Protection and immune responses induced by attenuated Salmonella typhimurium UK-1 strains.
Zhang X; Kelly SM; Bollen W; Curtiss R
Microb Pathog; 1999 Mar; 26(3):121-30. PubMed ID: 10089152
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Spleen-Induced Fimbria Production in Recombinant Attenuated
Łaniewski P; Baek CH; Roland KL; Curtiss R
mBio; 2017 Aug; 8(4):. PubMed ID: 28830946
[No Abstract] [Full Text] [Related]
20. Molecular and phenotypic analysis of the CS54 island of Salmonella enterica serotype typhimurium: identification of intestinal colonization and persistence determinants.
Kingsley RA; Humphries AD; Weening EH; De Zoete MR; Winter S; Papaconstantinopoulou A; Dougan G; Bäumler AJ
Infect Immun; 2003 Feb; 71(2):629-40. PubMed ID: 12540539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
